Status:
TERMINATED
Prospective L-arginine Study
Lead Sponsor:
University of Michigan
Conditions:
Heart Transplant
Eligibility:
All Genders
8+ years
Phase:
PHASE1
Brief Summary
HYPOTHESIS The investigators primary hypothesis is that peripheral endothelial function and exercise tolerance will be abnormal in the population of young heart transplant patients at baseline, and th...
Eligibility Criteria
Inclusion
- University of Michigan Pediatric Heart Transplant Clinic patient.
- Greater than or equal to 8 years of age.
- Heart transplant between 1 and 8 years prior to enrollment in the study
Exclusion
- Relative hypotension for age
- Refusal to participate
- Inability to cooperate with Endo-PAT testing
- Pregnant or nursing women.
- Insulin dependent diabetes
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01485757
Start Date
July 1 2011
End Date
July 1 2015
Last Update
January 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Pediatric Heart Transplant Clinic
Ann Arbor, Michigan, United States, 48109